Integral Health Asset Management, LLC 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Integral Health Asset Management, LLC disclosed 84 US equity positions worth $2.0bn in its Q4 2025 13F filing. The largest position was INSM at 11.0% of the reported book, followed by RVMD and VERA. Against the Q3 2025 filing, it opened 7 new positions, added to 30 and reduced 8 among the top 50 holdings.
What did Integral Health Asset Management, LLC own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 11.0% | $217.6m | 1,250,000 | -22% | reduced |
| 2 | RVMD REVOLUTION MEDICINES INC | Healthcare | 4.8% | $95.6m | 1,200,000 | 200% | added |
| 3 | VERA VERA THERAPEUTICS INC | Healthcare | 4.6% | $91.2m | 1,800,000 | 6% | added |
| 4 | CYTK CYTOKINETICS INC | Healthcare | 4.5% | $89.0m | 1,400,000 | 0% | held |
| 5 | REGN REGENERON PHARMACEUTICALS | Healthcare | 4.1% | $81.0m | 105,000 | 110% | added |
| 6 | MDT MEDTRONIC PLC | Healthcare | 3.3% | $64.8m | 675,000 | 350% | added |
| 7 | ISRG INTUITIVE SURGICAL INC | Healthcare | 3.2% | $62.3m | 110,000 | 340% | added |
| 8 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.6% | $50.8m | 475,000 | 116% | added |
| 9 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 2.2% | $43.5m | 2,200,000 | 38% | added |
| 10 | CAH CARDINAL HEALTH INC | Healthcare | 2.1% | $41.1m | 200,000 | 54% | added |
| 11 | CVS CVS HEALTH CORP | Healthcare | 2.0% | $39.7m | 500,000 | 150% | added |
| 12 | EWTX EDGEWISE THERAPEUTICS INC | 1.9% | $37.2m | 1,500,000 | 0% | held | |
| 13 | GKOS GLAUKOS CORP | Healthcare | 1.9% | $36.7m | 325,000 | 225% | added |
| 14 | NVS NOVARTIS AG | Healthcare | 1.7% | $34.5m | 250,000 | 25% | added |
| 15 | DXCM DEXCOM INC | Healthcare | 1.7% | $33.2m | 500,000 | – | new |
| 16 | AZN ASTRAZENECA PLC | Healthcare | 1.6% | $32.2m | 350,000 | 17% | added |
| 17 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 1.6% | $31.2m | 1,000,000 | – | new |
| 18 | PEN PENUMBRA INC | Healthcare | 1.6% | $31.1m | 100,000 | 100% | added |
| 19 | TFX TELEFLEX INCORPORATED | Healthcare | 1.5% | $30.5m | 250,000 | – | new |
| 20 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 1.4% | $28.1m | 750,000 | -35% | reduced |
| 21 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.4% | $27.7m | 325,000 | 62% | added |
| 22 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.4% | $27.2m | 750,000 | -50% | reduced |
| 23 | CNC CENTENE CORP DEL | Healthcare | 1.4% | $26.7m | 650,000 | 62% | added |
| 24 | COO COOPER COS INC | Healthcare | 1.3% | $26.6m | 325,000 | 242% | added |
| 25 | MRK MERCK & CO INC | Healthcare | 1.3% | $26.3m | 250,000 | – | new |
| 26 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.2% | $23.9m | 60,000 | 0% | held |
| 27 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 1.2% | $23.1m | 130,000 | 100% | added |
| 28 | QURE UNIQURE NV | 1.1% | $21.5m | 900,000 | 50% | added | |
| 29 | LLY ELI LILLY & CO | Healthcare | 1.1% | $21.5m | 20,000 | 0% | held |
| 30 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.1% | $21.5m | 225,000 | -25% | reduced |
| 31 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.1% | $21.3m | 150,000 | 0% | held |
| 32 | LFST LIFESTANCE HEALTH GROUP INC | Healthcare | 1.1% | $21.1m | 3,000,000 | 100% | added |
| 33 | ELV ELEVANCE HEALTH INC FORMERLY | Healthcare | 1.1% | $21.0m | 60,000 | 20% | added |
| 34 | UPB UPSTREAM BIO INC | 1.0% | $20.4m | 750,000 | 30% | added | |
| 35 | THC TENET HEALTHCARE CORP | Healthcare | 1.0% | $19.9m | 100,000 | -67% | reduced |
| 36 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.0% | $19.2m | 90,000 | 50% | added |
| 37 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.9% | $18.4m | 850,000 | 13% | added |
| 38 | DOCS DOXIMITY INC | Healthcare | 0.9% | $17.7m | 400,000 | 122% | added |
| 39 | BIIB BIOGEN INC | Healthcare | 0.9% | $17.6m | 100,000 | – | new |
| 40 | RGNX REGENXBIO INC | Healthcare | 0.9% | $17.3m | 1,200,000 | 9% | added |
| 41 | 430 TERNS PHARMACEUTICALS INC | 0.9% | $17.2m | 425,000 | -55% | reduced | |
| 42 | BHVN BIOHAVEN LTD | Healthcare | 0.9% | $16.9m | 1,500,000 | 131% | added |
| 43 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.8% | $16.5m | 50,000 | – | new |
| 44 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 0.8% | $16.4m | 200,000 | -20% | reduced |
| 45 | FMS FRESENIUS MEDICAL CARE AG | Healthcare | 0.8% | $15.5m | 650,000 | 44% | added |
| 46 | BEAM BEAM THERAPEUTICS INC | Healthcare | 0.8% | $15.2m | 550,000 | 38% | added |
| 47 | SLNOEUR SOLENO THERAPEUTICS INC | 0.8% | $15.0m | 325,000 | – | new | |
| 48 | RDNT RADNET INC | Healthcare | 0.7% | $14.3m | 200,000 | -33% | reduced |
| 49 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.7% | $13.2m | 300,000 | 200% | added |
| 50 | ACLXGBX ARCELLX INC | 0.7% | $13.0m | 200,000 | 33% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.